<DOC>
	<DOCNO>NCT02139189</DOCNO>
	<brief_summary>The purpose CorMatrix P-ECM safety feasibility study evaluate safety functional effect CorMatrix P-ECM .</brief_summary>
	<brief_title>Restore Myocardial Function With CorMatrix® ECM® Particulate ( P-ECM )</brief_title>
	<detailed_description>Evaluate safety CorMatrix ECM Particulate ( P-ECM ) deliver trans-epicardially subject leave ventricular ejection fraction ( LVEF ) 25 40 % coronary artery bypass grafting ( CABG )</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients age 18 75 year age Ischemic cardiomyopathy LVEF 25 40 % determine rest cardiac echocardiography Subjects severe chronic ischemic cardiomyopathy manifest Canadian Cardiovascular Society ( CCS ) class II great angina , and/or New York Heart Association ( NYHA ) class II great dyspnea Patients undergone diagnostic coronary angiography demonstrate &gt; 70 % diameter narrow least two major coronary artery branch OR &gt; 50 % diameter narrowing leave main coronary artery Significant leave ventricular systolic dysfunction evaluate echocardiography LV angiography ( LVEF 25 40 % ) due prior myocardial infarction . This area leave ventricular dysfunction akinetic severely hypokinetic , aneurysmal , assessed echocardiography LV angiogram Need urgent emergent revascularization Patients confirm myocardial infarction within 14 day , and/or rise cardiac biomarker protein ( i.e. , CKMB troponin ) , and/or worsen ECG change Patient support balloon pump preop Moderate severe ( &gt; 1+ ) aortic insufficiency determine echocardiogram History severe ventricular tachyarrhythmias require treatment Hypertrophic obstructive cardiomyopathy ( HOCM ) , restrictive cardiomyopathy , congenital heart disease Prior cardiac operation Anticipated concomitant surgical procedure time CABG ( e.g. , valve repair replacement , aneurysm resection , carotid endarterectomy , etc . ) Active infection , temperature great 37.5°C unexplained white blood cell count excess 15,000/mm3 within 48 hour prior surgery Hemoglobin le 10g/dL , white blood cell count less 4,000/mm3 , absolute neutrophil count le 1500/mm3 Primary coagulopathy platelet disorder , include thrombocytopenia absolute platelet count &lt; 80k active state disseminate intravascular coagulation Hemodynamically unstable patient , defined heart rate &lt; 40/min &gt; 100/min , and/or systolic blood pressure &lt; 90 mmHg &gt; 200 mmHg , and/or ongoing need intravenous inotropic vasopressor medication Severe pulmonary hypertension define PVR &gt; 8 Wood unit , unresponsive vasodilator therapy within 14 day enrollment History stroke history cerebral vascular disease significant ( &gt; 80 % ) extra cranial stenosis , without evidence collateral flow . ( Patients cerebral vascular disease history must acceptable stenosis document carotid doppler study ) Severe chronic renal insufficiency ( serum creatinine &gt; 2.5mg/dl , estimate glomular filtration rate ( eGFR ) &lt; 35 mL/min/1.73m2 need dialysis ) Evidence intrinsic hepatic disease define liver enzyme value ( AST ALT total bilirubin ) &gt; 5 time upper limit normal within 30 day enrollment ( diagnosis cirrhosis , chronic hepatitis ) , except association acute decompensation determine Investigator Significant peripheral vascular disease define claudication , rest pain leg ulceration Positive laboratory test result history syphilis , Hepatitis B Virus , Hepatitis C Virus , Human TLymphotropic Virus Type 1 2 , Human Immunodeficiency Virus Active know nondermatological malignancy undergo treatment include chemotherapy radiotherapy condition would place patient increase risk complication first 6 month procedure judgment attend cardiologist cardiac surgeon Immunosuppressive medication ( e.g . prednisone , cyclophosphamide , etanercept , etc . ) Previous solid organ transplantation anticipate need solid organ transplant heart ( exception corneal transplant ) Hematological disorder ( e.g. , aplastic anemia ) bone marrow disorder Myelodysplastic syndrome Any condition associate life expectancy le 6 month Contraindications magnetic resonance imaging ( MRI ) include presence implantable cardiac defibrillator ( ICD ) permanent pacemaker ( PPM ) , case anticipate ICD PPM implant prior 6 month followup claustrophobia ( thus preclude performance followup MRI scan ) Contraindication administration heparin , warfarin antiplatelet agent Known allergic reaction sensitivity porcine material Significant cognitive impairment psychiatric disease ( include drug alcohol abuse ) likely impair compliance study protocol Current participation participation within last 3 month study investigational drug , device , biologic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>